1. Home
  2. CYTK vs HXL Comparison

CYTK vs HXL Comparison

Compare CYTK & HXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • HXL
  • Stock Information
  • Founded
  • CYTK 1997
  • HXL 1946
  • Country
  • CYTK United States
  • HXL United States
  • Employees
  • CYTK N/A
  • HXL N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • HXL Major Chemicals
  • Sector
  • CYTK Health Care
  • HXL Industrials
  • Exchange
  • CYTK Nasdaq
  • HXL Nasdaq
  • Market Cap
  • CYTK 5.6B
  • HXL 4.6B
  • IPO Year
  • CYTK 2004
  • HXL N/A
  • Fundamental
  • Price
  • CYTK $37.73
  • HXL $59.30
  • Analyst Decision
  • CYTK Buy
  • HXL Hold
  • Analyst Count
  • CYTK 14
  • HXL 9
  • Target Price
  • CYTK $70.92
  • HXL $59.22
  • AVG Volume (30 Days)
  • CYTK 1.4M
  • HXL 1.1M
  • Earning Date
  • CYTK 08-07-2025
  • HXL 07-24-2025
  • Dividend Yield
  • CYTK N/A
  • HXL 1.09%
  • EPS Growth
  • CYTK N/A
  • HXL 29.12
  • EPS
  • CYTK N/A
  • HXL 1.51
  • Revenue
  • CYTK $19,218,000.00
  • HXL $1,887,200,000.00
  • Revenue This Year
  • CYTK $27.08
  • HXL $1.42
  • Revenue Next Year
  • CYTK $652.09
  • HXL $11.14
  • P/E Ratio
  • CYTK N/A
  • HXL $41.32
  • Revenue Growth
  • CYTK 412.21
  • HXL 4.63
  • 52 Week Low
  • CYTK $29.31
  • HXL $45.28
  • 52 Week High
  • CYTK $61.38
  • HXL $71.05
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 55.97
  • HXL 52.24
  • Support Level
  • CYTK $36.71
  • HXL $59.55
  • Resistance Level
  • CYTK $38.54
  • HXL $63.45
  • Average True Range (ATR)
  • CYTK 1.33
  • HXL 1.37
  • MACD
  • CYTK -0.03
  • HXL 0.04
  • Stochastic Oscillator
  • CYTK 61.38
  • HXL 33.03

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About HXL Hexcel Corporation

Founded in 1948, Hexcel designs and manufactures a range of highly engineered composite fibers, fabrics, resins, and structures for use in the commercial aerospace, defense, and high-performance automotive markets. These are lighter than metal and perform under rigorous conditions in aircraft frames, wings, engines, and other components and subassemblies. The company's name derives from the six-sided honeycomb structures that lend many of its products their light weight and rigidity. Hexcel's biggest customers are Airbus (38% of 2022 sales) and Boeing (25% of prepandemic sales) and their respective subcontractors.

Share on Social Networks: